
Tony Edge, Stephane Moreau, Carsten Paul, and Fraser McLeod discuss the latest trends and developments in LC.

Tony Edge, Stephane Moreau, Carsten Paul, and Fraser McLeod discuss the latest trends and developments in LC.

LCGC’s Senior Technical Editor uses artificial intelligence (AI) platform ChatGPT to answer questions about the role of AI in separation science. Do you agree with ChatGPT?

A recent study from the University of Lyon demonstrated how mass spectrometry techniques, when coupled to data-independent acquisition (DIA), can advance omics research.

As opposed to targeted metabolomics which looks only at a predetermined set of metabolites or their pathways, an untargeted approach was preferred by this research team because of its unbiased yet still comprehensive nature.

In preparation for ASMS 2024, we recently interviewed Uri Keshet of the University of California, Davis about his upcoming presentation and expectations for the conference.

During the 18th International Symposium on Hyphenated Techniques in Chromatography and Separation Technology, experts presented a workshop on different ways multidimensional liquid chromatography can be applied.

During the 18th International Symposium on Hyphenated Techniques in Chromatography and Separation Technology, experts presented a workshop on emerging industrial applications in MS.

Here are the top five articles that the editors of LCGC International published this week.

In this interview for ASMS 2024, Liusheng Huang of the University of California San Francisco discusses his upcoming presentation about performing microvolume analysis on antimalarial drugs.

Xinyi Biyan is a Chinese patent medicine with significant therapeutic effects, widely used clinically to treat acute and chronic rhinitis or allergic rhinitis.

LCGC International interviewed Peter Horvatovich of the University of Groningen about his upcoming presentation at ASMS and his expectations for the convention.

Scientists from the Lunan Pharmaceutical Group explored the use of UHPLC-MS/MS to test the effects of Shouhui Tongbian capsules (SHTBs) on slow transit constipation (STC).

Webcasts
Webinar Date/Time: Airing 1: Thursday, May 30, 2024 at 11am EDT | 12pm CDT | 8am PDT Airing 2: Friday, May 31, 2024 at 11am CST (Chinese Standard Time) | 12pm JST | 1pm AEST

Scientists from Chongqing University Cancer Hospital recently developed a new system for analyzing the potential impact of retention time (RT) prediction on targeted LC–MS-based lipidomics.

Brivaracetam has been approved for prescription use in the last decade for treatment of patients experiencing focal, or partial, seizures.

Here are the top five articles that the editors of LCGC International published this week.

Scientists from Florida State University used Marfey’s reagent and reversed-phase liquid chromatography–tandem mass spectrometry (LC–MS/MS) to analyze D-amino acids.

Researchers propose a suite of batch effect removal neural networks in large liquid chromatography-mass spectrometry experiments to maximize sample classification performance between conditions.

U.S. Environmental Protection Agency (EPA) Method 1633 signifies a pivotal shift in per- and polyfluoroalkyl substance (PFAS) determination, extending beyond drinking water.

Yelena Sapozhnikova from the United States Department of Agriculture spoke to The Column about her innovative research investigating PFAS in plastic food storage bags using targeted and non-targeted liquid chromatography–tandem mass spectrometry.

Michelle Colgrave of Edith Cowan University and Australia’s national science agency is the recipient of the 2024 Harvey W. Wiley Award.

French scientists recently created a new analytical method for quantifying micropollutants in different species of gammarids.

Here are the top five articles that the editors of LCGC International published this week.

Scientists from Hangzhou Medical College recently recorded the effectiveness of novel quality control strategies for the determination of vitamin D using liquid chromatography–tandem mass spectrometry (LC–MS/MS).

HRIM-MS has shown unique capabilities when used to analyze cyclic peptide therapeutics, and enhances the analysis of biopharmaceuticals by efficiently filtering out interfering compounds for direct analysis within a complex mixture. These findings demonstrate the technique's utility and versatility.